1. Introduction {#sec1}
===============

Colorectal cancer (CRC) is a malignant tumor that ranks third in terms of incidence and second in terms of mortality worldwide \[[@B1]\]. Similarly, the incidence and mortality of CRC rank fifth in China \[[@B2]\]. Despite dramatic reduction in the overall CRC incidence and mortality \[[@B3], [@B4]\], the morbidity rate in China is still rising from 2000 to 2011 \[[@B2]\]. Hence, further research is desperately needed to elucidate the causes for the increasing burden of CRC and to advance treatments for tumor subtypes with low response rates to current therapies. Treatment according to the distinctive tumor biology is an effective means to reduce the mortality of patients with CRC, as well as the detection of biomarkers that enable the stratification of patients with CRC into different prognostic subgroups and in relation therapeutic response \[[@B5]\]. Advances in RNA sequencing technologies and bioinformatics analysis provide novel potential biomarkers and drug targets for tumor treatment \[[@B6]\]. Weighted gene coexpression network analysis (WGCNA), as a systems biology algorithm, can enable the identification of highly coexpressed gene clusters (modules) \[[@B7]\]. Then, such interest modules and hub genes related to clinical traits can be screened out and used to identify candidate biomarkers \[[@B8]\]. The robust rank aggregation (RRA) method can be used to integrate multiple sets of chip data gene lists and to perform comprehensive reordering to find the most significant difference genes \[[@B9]\]. RRA prevents cross-platform standardization processing, and the number of samples per chip has no strict limit, which is of great significance for the effective evaluation of the results of different gene expression profiles \[[@B10]\].

In our study, we performed WGCNA on GSE68468 and screened out the key gene modules and hub genes significantly associated with the CRC histology. Additionally, we conducted RRA on six raw data (i.e., GSE25070, GSE44076, GSE44861, GSE21510, GSE9348, and GSE21815) and calculated the top 50 robust DEGs in all the six data by using the library "RobustRankAggreg" package. We analyzed the integrated genes between DEGs and hub genes in the key module by using Kaplan--Meier analysis in the TCGA database and obtained the candidate genes associated with OS. Finally, we validated the candidate gene in our clinical CRC specimens. The candidate genes screened from the database and verified using our clinical pathological data might have significant clinical implications for CRC diagnosis, treatment, and prognosis prediction.

2. Results {#sec2}
==========

2.1. Weighted Gene Coexpression Network Construction and Module Detection {#sec2.1}
-------------------------------------------------------------------------

We performed WGCNA to find the highly correlated genes. The sample dendrogram and trait heatmap are shown in [Figure S1A](#supplementary-material-1){ref-type="supplementary-material"}. As shown in [Figure S1B](#supplementary-material-1){ref-type="supplementary-material"}, power value 4 was set to guarantee the high-scale independence and low mean connectivity of 13515 genes. We set the dissimilarity as 0.25 to merge similar modules ([Figure S1C](#supplementary-material-1){ref-type="supplementary-material"}), and 22 modules were generated ([Figure 1(a)](#fig1){ref-type="fig"}). Furthermore, the interaction relationship network of 22 modules was plotted ([Figure 1(b)](#fig1){ref-type="fig"}). From those obtained modules, the red module had the deepest association with tumor histology (cor = −0.76, *P*=1*E* − 73), which was selected for further analysis ([Figure 1(c)](#fig1){ref-type="fig"}). Additionally, the module memberships in the red module and the gene significance had a high correlation (0.89) and a high *P* value (\<1*e* − 200) ([Figure 1(d)](#fig1){ref-type="fig"}), suggesting its suitability for identifying the hub genes associated with CRC occurrence and metastasis.

2.2. Coexpression Network Construction and Hub Gene Identification {#sec2.2}
------------------------------------------------------------------

In our study, we obtained 616 genes in the red modules. The hub genes in the red module were filtered by a condition of the weight value being greater than 0.15, and a total of 37 edges were obtained and are visualized in [Figure 2](#fig2){ref-type="fig"}. The top 10 hub genes were CA2, MS4A12, DHRS11, GUCA2A, ETHE1, CLCA4, TSPAN1, HSD11B2, AQP8, and CHP2.

2.3. RRA Analysis {#sec2.3}
-----------------

We calculated DEGs expressed between the cancerous and adjacent tissues in each dataset and displayed the results by using volcano maps (Figures [S2a](#supplementary-material-1){ref-type="supplementary-material"}--[f](#supplementary-material-1){ref-type="supplementary-material"}). Then, DEGs in all six data were recalculated and reorganized using the library "RobustRankAggreg" package. A total of 464 robust DEGs were identified, including 176 upregulated genes and 288 downregulated genes ([Table 1](#tab1){ref-type="table"}), by using adjusted *P*  *value* \< 0.01 and \|logFC\| ≥ 1 as the cutoff criteria. The 50 most prominent up- and downregulated genes were screened and are visualized in Figures [3(a)](#fig3){ref-type="fig"} and [3(b)](#fig3){ref-type="fig"}.

2.4. Survival Analysis in the TCGA Database and Validation in the GEO Database {#sec2.4}
------------------------------------------------------------------------------

By taking the intersection of the 50 downregulated DEGs and hub genes in the red module from WGCNA ([Figure 4(a)](#fig4){ref-type="fig"}), we obtained 19 interacting genes.

K-M analysis was conducted to evaluate the relationship between gene expression and the overall survival (OS) of CRC, and only GUCA2A was clearly related to the OS of CRC patients in the TCGA database. Patients with a lower GUCA2A expression had a significantly shorter OS than those with a higher expression (*P* \< 0.05) ([Figure 4(b)](#fig4){ref-type="fig"}). Obviously, GUCA2A was abnormally expressed in tumor tissues and was significantly different in TCGA and GEO databases (Figures [4(c)](#fig4){ref-type="fig"} and [4(d)](#fig4){ref-type="fig"}). We further validated the aberrant expression of GUCA2A in GSE68468, which contains both CRC tissues and cellular RNA-Seq data. Compared with adjacent normal tissues, the expression of GUCA2A in tumor and metastatic tissues was significantly low, and the normal liver and lung tissues had the lowest expression value (*P* \< 0.05) ([Figure 4(e)](#fig4){ref-type="fig"}). The colonic epithelial cell (NCM460) has the highest GUCA2A expression compared with other CRC cells ([Figure 4(f)](#fig4){ref-type="fig"}).

2.5. Human Tissue Samples and Quantitative Real-Time PCR {#sec2.5}
--------------------------------------------------------

We performed real-time PCR to examine the levels of GUCA2A in 31 paired CRC/adjacent tissues to further validate the dysregulated expression of GUCA2A ([Figure 4(g)](#fig4){ref-type="fig"}). Then, we further evaluated the diagnostic value of GUCA2A for CRC tissues and normal counterparts using ROC curve analyses. The results showed that the area under the ROC curve (AUC) was 0.835 (*P* \< 0.001; sensitivity: 0.806; specificity: 0.903). These results suggest that GUCA2A downregulation may play an important role in colorectal tumorigenesis and has a potential diagnostic value for CRC patients.

2.6. Pathway Analysis {#sec2.6}
---------------------

The pathway enrichment analysis of GUCA2A coexpressed genes was conducted in the ConsensusPathDB human database. From the 16 pathways shown in [Figure 5](#fig5){ref-type="fig"}, the transport of small molecules and metabolism are prominent.

3. Discussion {#sec3}
=============

Early detection and complete resection before metastasis are considered the only curative therapy for CRC \[[@B11]\]. The five-year survival rate of CRC patients was obviously better when the localized disease was detected at an early stage than that of CRC patients with distant metastasis. Cancer is a molecularly heterogeneous disease, and none of the currently identified biomarkers are sensitive and specific enough for reliable CRC screening in the clinical setting. Thus, identifying novel molecular biomarkers has significant clinical benefits.

In our study, we first performed WGCNA for GSE68468 and screened the pathologically related hub genes. We conducted RRA analysis for six datasets and screened the top 100 robust DEGs, which had a high or low expression in all expression profiles. By taking the intersection, we obtained 19 candidate genes, and only the expression of GUCA2A was associated with the OS of CRC patients in the TCGA database. We found that GUCA2A was prominent and top-ranking in both the hub gene network ([Figure 2](#fig2){ref-type="fig"}) and robust DEGs ([Figure 3(b)](#fig3){ref-type="fig"}), indicating its value in tumorigenesis.

Guanylin (GUCA2A) and uroguanylin (GUCA2B) are two peptide hormones that function as paracrine endogenous ligands for the guanylate cyclase-C (GUCY2C) receptor \[[@B12]\]. A previous study indicated the role of GUCY2C signaling in facilitating mucosal wounding and inflammation mediation, in part, through the control of resistin-like molecule *β* production \[[@B13]\]. GUCA2A, GUCA2B, and GUCY2C are downregulated in inflammatory bowel disease \[[@B14]\], which may have implications in inflammatory bowel disease pathogenesis. A recent study suggests that GUCY2C can suppress tumor progress \[[@B15]\] in the intestine, and the loss of the GUCY2C signaling cascade increases CRC susceptibility \[[@B16]\]. Intestinal homeostasis disruption and CRC tumorigenesis are associated with a fairly common loss of GUCA2A and GUCA2B \[[@B17]--[@B19]\]. Bashir et al. revealed the possibility of GUCA2A loss silencing GUCY2C, which leads to microsatellite instability tumor \[[@B20]\].

Consistent with the expression of GUCA2A in our study, the expression of GUCA2B was significantly downregulated in CRC tissues and had a relative high weight in the red module, which further indicates that GUCA2A and GUCA2B may play a consistent role in CRC neoplasia.

In conclusion, we revealed that GUCA2A was downregulated in CRC tissues. Aberrantly expressed GUCA2A can be a candidate marker of poor prognosis in patients with CRC, which may be a therapeutic target for precision medicine in cervical cancer. However, further studies are still needed to explore the underlying molecular mechanism through which GUCA2A plays a role in CRC. However, future in vivo and in vitro experiments are still required to explore the mechanisms underlying the roles of GUCA2A in CRC.

4. Methods {#sec4}
==========

4.1. WGCNA Construction and Module Detection {#sec4.1}
--------------------------------------------

We performed WGCNA to microarray data GSE68468 generated from 378 CRC tissue samples, and the "WGCNA" package in R 3.5.1 was used to construct a coexpression network. WGCNA seeks to identify modules of densely interconnected genes by searching for genes with similar patterns of connection strengths or high topological overlap. For each dataset, Pearson correlation coefficients were calculated for all pairwise comparisons of expressed genes across all samples. Genes with similar expression profiles were classified into modules based on the TOM dissimilarity with a minimum size of 30 for the gene dendrogram and visualized via hierarchical clustering \[[@B7]\]. Then, the modules whose eigengenes were highly correlated (correlation above 0.7) were merged. The gene network was visualized with randomly selected 400 genes.

The resulting Pearson correlation matrix was transformed into a matrix of connection strengths (that is, an adjacency matrix) by using a power function (connection). All the modules were assigned to the corresponding color. The relationships of modules and clinical traits (i.e., disease status, histology, and organism part) were calculated. Among these clinical traits, pathology, including normal mucosa, polyps, CRC tissue, CRC with metastases, and normal lung/liver tissues, can reflect the occurrence and metastasis of CRC. The associations of individual genes with the clinical trait, namely, gene significance (GS), and the module eigengenes, namely, module membership (MM), were evaluated. Then, the correlation between GS and MM was calculated, and the highly correlated interest module can be used to construct the coexpression network and identify the hub genes.

4.2. Coexpression Network Construction and Hub Gene Identification {#sec4.2}
------------------------------------------------------------------

The genes in the key modules screened from WGCNA were further analyzed.

We filtered the hub genes by a condition of the weight value (\>0.15) and visualized them using Cytoscape 3.6.0 \[[@B21]\].

4.3. Robust Rank Aggregation (RRA) Analysis {#sec4.3}
-------------------------------------------

To further increase the reliability of the results and screen out the ideal candidate, we enrolled six published colorectal microarray data (i.e., GSE25070, GSE44076, GSE44861, GSE21510, GSE9348, and GSE21815) \[[@B22]--[@B31]\] from the GEO database, which have 530 CRC tissues and 50 normal tissues in our study ([Table 2](#tab2){ref-type="table"}). After screening DEGs (adjusted *P* value \< 0.05 and \|logFC\| ≥ 2) in each dataset by using the "limma" package \[[@B32]\], the RRA method was used to identify significantly robust DEGs by using the library "RobustRankAggreg" package in R 3.5.1. The statistically significant DEGs were defined to have adjusted *P* value \< 0.01 and \|logFC\| ≥ 1. Finally, the top 50 up- and downregulated DEGs were selected and visualized by using a heatmap.

4.4. Survival Analysis in the TCGA Database {#sec4.4}
-------------------------------------------

In order to increase the reliability of the results, the intersection of hub genes in the red module from WGCNA and 50 downregulated robust DEGs was performed and analyzed. Kaplan--Meier (K-M) analysis was conducted to evaluate the relationship between gene expression and the overall survival (OS) of 617 CRC patients in The Cancer Genome Atlas (TCGA) database (<https://cancergenome.nih.gov/>). Patients were classified into high- or low-expression groups according to the median value. Then, genes associated with CRC survival were screened.

4.5. Human Tissue Samples and Quantitative Real-Time PCR {#sec4.5}
--------------------------------------------------------

Overall, the 31 CRC and adjacent normal tissues obtained at Jiangsu Cancer Hospital (Nanjing, China) were frozen immediately after surgical resection and kept at 80°C until further analysis. Tumor histopathology was classified according to the World Health Organization Classification of Tumors system. The present study was done with the approval of the local ethics committee.

RNA isolation (Takara, Dalian, China) was performed according to the manufacturer\'s instructions. Reverse transcription was conducted with a PrimeScript RT reagent kit (Takara, Kusatsu City, Shiga, Japan) and the fluorescent quantitative experiment with ABI qPCR 7300 (Torrance, CA). The PCR reactant mix consisted of 2 *µ*l cDNA solution, 10 *μ*l 2× PowerUp™ SYBR™ Green Master Mix (Thermo Fisher Scientific, Carlsbad, CA), 0.5 *μ*l of 10 *μ*M forward and reverse PCR primer, and 7 *μ*l DNA template Nuclease-Free Water. The PCR conditions were set as follows: denaturation at 50°C for 2 min, 95°C for 2 min, 95°C for 15 s, and 60°C for 1 min with 40 cycles. A GAPDH primer set was used as an internal control.

4.6. Pathway Analysis {#sec4.6}
---------------------

We performed pathway enrichment analysis for the coexpressed genes to explore the possible mechanism of the candidate gene in CRC. The coexpressed genes were obtained from the TCGA database, and the top 100 genes with the highest Pearson correlation coefficient were considered to be significantly coexpressed ([Table 3](#tab3){ref-type="table"}). Pathway enrichment analysis was performed by using the ConsensusPathDB human database (<http://cpdb.molgen.mpg.de/>) \[[@B33]\]. The overrepresentation gene set analysis was utilized, and the following pathway databases were enrolled in our analysis: Manual upload, NetPath, SignaLink, PID, EHMN, HumanCyc, INOH, KEGG, BioCarta, WikiPathways, SMPDB, and PharmGKB. Minimum overlap input list \>5 and *P* value cutoff \<0.01 were considered significant enrichment.
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###### 

S1: sample dendrogram and soft-thresholding value estimation. (A) Sample dendrogram and trait heatmap. The three traits correspond to the disease status, histology, and organism part, respectively. (B) Scale independence and mean connectivity of soft-thresholding values (*β*). (C) Clustering of module eigengenes. The dissimilarity was set as 0.25 to merge the similar modules. S2: volcano plots of DEGs between cancerous and adjacent tissues in six microarray data.

###### 

Click here for additional data file.

![Modules defined by the WGCNA. (a) Dendrogram tree represents the clustering dendrogram of genes in GSE68468, and the bottom colorful bands represent 22 modules assigned by genes. (b) A network heatmap plot of 400 genes. The intensity of the red color indicates the strength of the correlation between pairs of modules on a linear scale. (c) Correlation between modules and clinicopathologic features. The correlation coefficient and corresponding *P* value of each module are shown in each cell. (d) Correlation (Pearson) between module membership and gene significance for the red module.](BRI2019-6469420.001){#fig1}

![Coexpression network of hub genes. The hub genes in the red modules were filtered by a condition of the weight value (\>0.15) and visualized using Cytoscape 3.6.0. The size and color of the edge represent the intensity of weight interaction in the network.](BRI2019-6469420.002){#fig2}

![Top 50 robust DEGs identified in the six microarray data (i.e., GSE25070, GSE44076, GSE44861, GSE21510, GSE9348, and GSE21815) from the GEO database: (a) upregulated genes; (b)downregulated genes. These genes were ranked by adjusted *P* value.](BRI2019-6469420.003){#fig3}

![Aberrant expression of GUCA2A can be a candidate prognostic biomarker in CRC. (a) Venn diagram of the robust DEGs and genes in the red module revealed 19 interacting genes. Set 1: hub genes in the red module; Set 2: downregulated DEGs. (b) Five-year OS of CRC patients from the TCGA database (*P*=0.048). Patients with a low expression of GUCA2A have a significantly shorter OS. (c) GUCA2A expression in the TCGA database. (d) GUAC2A expression between CRC tissues and normal tissues in the six datasets. (e) GUAC2A expression in different tissue histology. (f) CRC cells in GSE68468. (g) GUCA2A expression levels in human CRC and their matched adjacent normal tissues. (h) ROC curves of tissue GUCA2A expression for differentiating CRC tissue from normal tissue. ^*∗∗∗*^ *P* \< 0.001.](BRI2019-6469420.004){#fig4}

![Pathway enrichment analysis for GUCA2A coexpressed genes.](BRI2019-6469420.005){#fig5}

###### 

Whole DEGs (176 upregulated genes and 288 downregulated genes) identified in the six microarray data from the GEO database by using adjusted *P* value \< 0.01 and \|logFC\| ≥ 1 as the cutoff criteria.

  Name                   *P* value      Adjusted *P* value   LogFC
  ---------------------- -------------- -------------------- ----------
  *Upregulated DEGs*                                         
  MMP7                   1.04*E* − 16   2.71*E* − 12         3.717319
  THBS2                  3.32*E* − 16   8.67*E* − 12         2.821997
  TGFBI                  7.96*E* − 16   2.08*E* − 11         2.584099
  MMP3                   1.59*E* − 15   4.15*E* − 11         2.998933
  DPEP1                  4.59*E* − 15   1.20*E* − 10         3.250292
  CDH3                   4.60*E* − 14   1.20*E* − 09         3.266416
  KRT23                  1.55*E* − 13   4.05*E* − 09         3.658825
  NFE2L3                 1.32*E* − 12   3.45*E* − 08         2.149137
  GZMB                   1.36*E* − 12   3.55*E* − 08         2.078558
  COL11A1                3.42*E* − 12   8.95*E* − 08         2.728714
  CXCL1                  3.70*E* − 12   9.65*E* − 08         2.210194
  CEMIP                  4.96*E* − 12   1.30*E* − 07         2.894223
  FAP                    5.19*E* − 12   1.36*E* − 07         2.449763
  SLCO1B3                6.55*E* − 12   1.71*E* − 07         2.197776
  CLDN1                  7.48*E* − 12   1.95*E* − 07         2.916603
  MYC                    1.15*E* − 11   2.99*E* − 07         1.831720
  IFITM1                 1.15*E* − 11   2.99*E* − 07         1.625712
  TESC                   2.53*E* − 11   6.61*E* − 07         2.108654
  CXCL11                 2.95*E* − 11   7.70*E* − 07         1.989137
  EDNRA                  3.02*E* − 11   7.89*E* − 07         1.496142
  MMP1                   3.29*E* − 11   8.60*E* − 07         2.399938
  FOXQ1                  5.40*E* − 11   1.41*E* − 06         2.749133
  TPX2                   5.42*E* − 11   1.41*E* − 06         1.634694
  COL4A1                 5.77*E* − 11   1.51*E* − 06         1.630033
  TCN1                   7.96*E* − 11   2.08*E* − 06         1.926601
  EGFL6                  9.09*E* − 11   2.38*E* − 06         1.752245
  TRIP13                 9.50*E* − 11   2.48*E* − 06         1.729510
  PMAIP1                 1.01*E* − 10   2.63*E* − 06         1.621771
  CXCL3                  1.19*E* − 10   3.10*E* − 06         1.933844
  PSAT1                  1.33*E* − 10   3.48*E* − 06         1.749995
  CTHRC1                 1.36*E* − 10   3.56*E* − 06         2.547903
  PLS3                   1.76*E* − 10   4.61*E* − 06         1.561012
  INHBA                  1.82*E* − 10   4.76*E* − 06         2.470231
  IFITM2                 2.22*E* − 10   5.81*E* − 06         1.477155
  PHLDA1                 2.77*E* − 10   7.25*E* − 06         2.025229
  CSE1L                  2.77*E* − 10   7.25*E* − 06         1.509054
  BMP4                   4.28*E* − 10   1.12*E* − 05         1.311002
  CRNDE                  4.93*E* − 10   1.29*E* − 05         2.196882
  S100A9                 5.05*E* − 10   1.32*E* − 05         1.793278
  CDK4                   6.20*E* − 10   1.62*E* − 05         1.268501
  XPOT                   6.54*E* − 10   1.71*E* − 05         1.350678
  LY6E                   6.54*E* − 10   1.71*E* − 05         1.773015
  CCL20                  8.45*E* − 10   2.21*E* − 05         1.681642
  TSPAN5                 8.63*E* − 10   2.25*E* − 05         1.300671
  CDC25B                 9.62*E* − 10   2.51*E* − 05         1.477785
  LGR5                   1.03*E* − 09   2.69*E* − 05         1.765688
  ASCL2                  1.06*E* − 09   2.78*E* − 05         2.270850
  IFITM3                 1.12*E* − 09   2.94*E* − 05         1.535829
  PLAU                   1.35*E* − 09   3.52*E* − 05         1.449998
  RIPK2                  1.40*E* − 09   3.65*E* − 05         1.304180
  COL5A2                 1.42*E* − 09   3.72*E* − 05         1.709418
  CXCL10                 1.45*E* − 09   3.78*E* − 05         1.832510
  DUSP14                 1.49*E* − 09   3.89*E* − 05         1.604280
  TRIB3                  1.52*E* − 09   3.97*E* − 05         2.009118
  CKMT2                  1.71*E* − 09   4.46*E* − 05         2.047320
  CEL                    1.77*E* − 09   4.62*E* − 05         1.921534
  TGIF2                  1.82*E* − 09   4.74*E* − 05         1.594622
  HOMER1                 1.89*E* − 09   4.94*E* − 05         1.595741
  SRPX2                  1.97*E* − 09   5.15*E* − 05         1.759897
  SLC7A5                 2.05*E* − 09   5.37*E* − 05         1.907805
  UBD                    2.06*E* − 09   5.38*E* − 05         1.848031
  GPSM2                  2.90*E* − 09   7.58*E* − 05         1.310352
  AZGP1                  3.52*E* − 09   9.20*E* − 05         2.058214
  AURKA                  3.81*E* − 09   9.96*E* − 05         1.248453
  STC2                   3.90*E* − 09   0.000102             1.838371
  SULF1                  3.90*E* − 09   0.000102             2.003268
  ATAD2                  4.09*E* − 09   0.000107             1.500415
  TMEM158                4.11*E* − 09   0.000107             1.212075
  PPAT                   4.12*E* − 09   0.000108             1.305250
  SPP1                   4.13*E* − 09   0.000108             2.205887
  CXCL2                  4.36*E* − 09   0.000114             1.826375
  COL1A2                 4.44*E* − 09   0.000116             1.882105
  SLC7A11                5.29*E* − 09   0.000138             1.208023
  TIMP1                  5.69*E* − 09   0.000149             1.661168
  MMP12                  6.08*E* − 09   0.000159             1.933314
  SCD                    6.11*E* − 09   0.000160             1.564105
  SOX9                   6.43*E* − 09   0.000168             1.352557
  CXCL9                  6.92*E* − 09   0.000181             1.461166
  HSPH1                  8.01*E* − 09   0.000209             1.238503
  GDPD5                  8.12*E* − 09   0.000212             1.308392
  CXCL8                  8.27*E* − 09   0.000216             2.588362
  COL1A1                 8.38*E* − 09   0.000219             1.769908
  FABP6                  8.52*E* − 09   0.000223             2.079844
  PMEPA1                 8.52*E* − 09   0.000223             1.333566
  ANXA9                  9.83*E* − 09   0.000257             1.608179
  TDGF1P3                1.15*E* − 08   0.000301             1.841176
  CEP55                  1.22*E* − 08   0.000319             1.470764
  COL10A1                1.27*E* − 08   0.000331             1.780470
  MCM10                  1.37*E* − 08   0.000358             1.211513
  MPP6                   1.51*E* − 08   0.000396             1.432320
  PROX1                  1.58*E* − 08   0.000413             1.364230
  TEAD4                  1.65*E* − 08   0.000431             1.447381
  CLDN2                  1.72*E* − 08   0.000449             1.698260
  ODAM                   1.79*E* − 08   0.000468             1.471032
  MTHFD2                 1.83*E* − 08   0.000478             1.111261
  KRT6B                  1.85*E* − 08   0.000484             1.485079
  HILPDA                 1.87*E* − 08   0.000488             1.488635
  DACH1                  2.14*E* − 08   0.000559             1.610398
  ESM1                   2.17*E* − 08   0.000568             1.708858
  CYP4X1                 2.22*E* − 08   0.000581             1.382114
  GNG4                   2.25*E* − 08   0.000588             1.178933
  ARID3A                 2.35*E* − 08   0.000613             1.275140
  PPBP                   2.38*E* − 08   0.000621             1.748166
  EPHX4                  2.42*E* − 08   0.000633             2.381989
  LRP8                   2.67*E* − 08   0.000697             1.522085
  PTP4A3                 2.67*E* − 08   0.000697             1.183443
  SERPINE2               2.67*E* − 08   0.000697             1.154912
  AGT                    2.81*E* − 08   0.000734             1.405610
  C2                     2.84*E* − 08   0.000743             1.372973
  RRM2                   2.86*E* − 08   0.000748             1.196973
  NEBL                   3.49*E* − 08   0.000912             1.521795
  RPP40                  3.49*E* − 08   0.000912             1.285132
  ARNTL2                 3.77*E* − 08   0.000984             1.419157
  AHCY                   3.84*E* − 08   0.001004             1.237807
  GTF2IRD1               3.95*E* − 08   0.001032             1.371062
  WNT2                   4.00*E* − 08   0.001044             1.452032
  TOP2A                  4.04*E* − 08   0.001057             1.372624
  PUS7                   4.09*E* − 08   0.001069             1.249772
  NMU                    4.30*E* − 08   0.001122             1.284463
  COL6A3                 4.44*E* − 08   0.001160             1.270615
  RNF43                  4.57*E* − 08   0.001195             1.397306
  COL5A1                 4.69*E* − 08   0.001226             1.191502
  CDK1                   4.70*E* − 08   0.001228             1.317782
  ETV4                   4.86*E* − 08   0.001271             2.204983
  PTGS2                  5.04*E* − 08   0.001317             1.233879
  CHEK1                  5.20*E* − 08   0.001358             1.126745
  MMP10                  5.41*E* − 08   0.001414             1.195256
  FZD3                   5.52*E* − 08   0.001442             1.089222
  UBE2C                  5.81*E* − 08   0.001518             1.241558
  RNASEH2A               6.16*E* − 08   0.001609             1.071208
  ENC1                   6.27*E* − 08   0.001637             1.375197
  IGF2BP3                6.37*E* − 08   0.001665             1.082776
  VSNL1                  6.75*E* − 08   0.001764             1.786437
  GALNT6                 6.79*E* − 08   0.001774             1.266153
  ERP27                  6.97*E* − 08   0.001821             1.218536
  PROCR                  7.73*E* − 08   0.002020             1.376152
  PAFAH1B3               7.88*E* − 08   0.002058             1.100418
  RFC3                   8.14*E* − 08   0.002126             1.372173
  NKRF                   8.14*E* − 08   0.002127             1.043072
  CXCL5                  9.69*E* − 08   0.002531             1.294918
  SQLE                   1.03*E* − 07   0.002700             1.308167
  EXOSC5                 1.08*E* − 07   0.002828             1.132422
  S100P                  1.13*E* − 07   0.002944             1.551099
  ELOVL5                 1.27*E* − 07   0.003331             1.176539
  ZAK                    1.29*E* − 07   0.003360             1.541699
  TCFL5                  1.45*E* − 07   0.003786             1.270140
  LAPTM4B                1.67*E* − 07   0.004376             1.026874
  CEBPB                  1.70*E* − 07   0.004431             1.333258
  SLCO4A1                1.83*E* − 07   0.004790             1.606904
  TTK                    1.89*E* − 07   0.004934             1.386804
  TMEM97                 1.98*E* − 07   0.005179             1.082142
  CHI3L1                 2.01*E* − 07   0.005239             1.621308
  PPM1H                  2.10*E* − 07   0.005475             1.353835
  SORD                   2.14*E* − 07   0.005591             1.037586
  CST1                   2.20*E* − 07   0.005747             1.894531
  CENPF                  2.46*E* − 07   0.006422             1.024242
  GTF3A                  2.47*E* − 07   0.006451             1.215577
  APCDD1                 2.59*E* − 07   0.006772             1.580775
  KIF4A                  2.59*E* − 07   0.006772             1.267447
  MFAP2                  2.65*E* − 07   0.006914             1.397671
  CCNB1                  2.77*E* − 07   0.007241             1.203637
  GDF15                  2.88*E* − 07   0.007514             1.563948
  NXT1                   2.93*E* − 07   0.007667             1.046948
  SHMT2                  2.95*E* − 07   0.007697             1.002641
  SNTB1                  2.96*E* − 07   0.007726             1.291950
  TACSTD2                2.97*E* − 07   0.007754             1.640872
  SNX10                  2.99*E* − 07   0.007814             1.021758
  SLC12A2                3.04*E* − 07   0.007933             1.134681
  TNFRSF12A              3.13*E* − 07   0.008190             1.332447
  SLC5A6                 3.25*E* − 07   0.008488             1.064032
  RUVBL1                 3.26*E* − 07   0.008513             1.066507
  FXYD5                  3.32*E* − 07   0.008680             1.172860
  ZNF239                 3.35*E* − 07   0.008745             1.158161
  REG1A                  3.40*E* − 07   0.008876             1.168719
  OLFML2B                3.57*E* − 07   0.009326             1.332885
  ERCC6L                 3.63*E* − 07   0.009472             1.325393
                                                             
  *Downregulated DEGs*                                       
  GUCA2B                 4.94*E* − 21   1.29*E* − 16         −5.47325
  GUCA2A                 5.63*E* − 20   1.47*E* − 15         −4.98756
  CA4                    9.10*E* − 20   2.38*E* − 15         −4.93587
  MS4A12                 2.15*E* − 19   5.61*E* − 15         −5.22647
  CA2                    3.16*E* − 19   8.27*E* − 15         −4.64843
  AQP8                   7.18*E* − 19   1.88*E* − 14         −5.22336
  CLCA1                  1.67*E* − 17   4.37*E* − 13         −4.41598
  CLCA4                  2.30*E* − 17   6.01*E* − 13         −5.78604
  AKR1B10                3.47*E* − 17   9.06*E* − 13         −3.66480
  CA1                    1.37*E* − 16   3.58*E* − 12         −4.85127
  HSD17B2                1.42*E* − 15   3.72*E* − 11         −3.65299
  GCG                    1.86*E* − 15   4.87*E* − 11         −4.24507
  CWH43                  3.10*E* − 15   8.09*E* − 11         −3.35700
  MT1M                   6.63*E* − 15   1.73*E* − 10         −3.74527
  CHP2                   6.63*E* − 15   1.73*E* − 10         −3.59700
  FCGBP                  9.37*E* − 15   2.45*E* − 10         −3.35836
  ADH1C                  1.89*E* − 14   4.93*E* − 10         −3.66678
  CD177                  7.18*E* − 14   1.88*E* − 09         −3.56989
  CA12                   1.04*E* − 13   2.73*E* − 09         −2.48416
  CHGA                   1.04*E* − 13   2.73*E* − 09         −3.21194
  SLC26A3                1.09*E* − 13   2.85*E* − 09         −3.26689
  CEACAM7                1.16*E* − 13   3.02*E* − 09         −3.26188
  PLAC8                  1.75*E* − 13   4.58*E* − 09         −2.93747
  CLDN8                  1.79*E* − 13   4.67*E* − 09         −4.07661
  PCK1                   3.95*E* − 13   1.03*E* − 08         −2.41432
  BEST2                  5.80*E* − 13   1.52*E* − 08         −2.88517
  GBA3                   6.08*E* − 13   1.59*E* − 08         −3.15495
  MT1H                   7.81*E* − 13   2.04*E* − 08         −2.45079
  HMGCS2                 1.28*E* − 12   3.35*E* − 08         −2.63704
  SI                     1.53*E* − 12   3.99*E* − 08         −3.18335
  GCNT3                  1.86*E* − 12   4.87*E* − 08         −2.55705
  EDN3                   2.02*E* − 12   5.29*E* − 08         −2.36855
  SLC26A2                2.58*E* − 12   6.74*E* − 08         −2.74311
  TSPAN1                 3.02*E* − 12   7.89*E* − 08         −2.43173
  UGT2B17                3.26*E* − 12   8.51*E* − 08         −2.68448
  BCAS1                  3.43*E* − 12   8.96*E* − 08         −2.14870
  LRRC19                 4.61*E* − 12   1.20*E* − 07         −2.60514
  LGALS2                 5.96*E* − 12   1.56*E* − 07         −2.50281
  ANPEP                  8.52*E* − 12   2.23*E* − 07         −2.96251
  VSIG2                  8.52*E* − 12   2.23*E* − 07         −2.90829
  MT1E                   9.09*E* − 12   2.37*E* − 07         −2.30341
  MT1G                   9.49*E* − 12   2.48*E* − 07         −2.13170
  NXPE4                  9.66*E* − 12   2.53*E* − 07         −2.93788
  KRT20                  9.69*E* − 12   2.53*E* − 07         −2.12657
  CA7                    1.29*E* − 11   3.38*E* − 07         −2.72816
  MT1F                   1.32*E* − 11   3.45*E* − 07         −2.15911
  KLF4                   1.38*E* − 11   3.59*E* − 07         −2.38010
  AHCYL2                 1.43*E* − 11   3.74*E* − 07         −2.24169
  ITLN1                  1.74*E* − 11   4.55*E* − 07         −3.42798
  HSD11B2                2.10*E* − 11   5.49*E* − 07         −2.34259
  NR3C2                  2.53*E* − 11   6.60*E* − 07         −2.37317
  EPB41L3                2.57*E* − 11   6.72*E* − 07         −2.39867
  ITM2C                  2.67*E* − 11   6.97*E* − 07         −2.12884
  MMP28                  2.86*E* − 11   7.48*E* − 07         −1.93771
  ZG16                   3.09*E* − 11   8.06*E* − 07         −4.23120
  ABCG2                  3.75*E* − 11   9.80*E* − 07         −3.20141
  SLC4A4                 4.13*E* − 11   1.08*E* − 06         −3.28247
  SCGB2A1                4.33*E* − 11   1.13*E* − 06         −2.48958
  MALL                   4.61*E* − 11   1.20*E* − 06         −2.29999
  TUBAL3                 4.92*E* − 11   1.29*E* − 06         −2.39086
  RUNDC3B                5.33*E* − 11   1.39*E* − 06         −1.89913
  NR1H4                  5.50*E* − 11   1.44*E* − 06         −2.46055
  SLC30A10               5.68*E* − 11   1.48*E* − 06         −3.22414
  PIGR                   6.05*E* − 11   1.58*E* − 06         −2.18018
  MUC2                   6.24*E* − 11   1.63*E* − 06         −2.62907
  HPGD                   6.74*E* − 11   1.76*E* − 06         −2.64497
  TSPAN7                 6.84*E* − 11   1.79*E* − 06         −2.30396
  PAPSS2                 1.30*E* − 10   3.39*E* − 06         −1.78856
  SLC17A4                1.31*E* − 10   3.43*E* − 06         −2.31184
  DHRS9                  1.36*E* − 10   3.56*E* − 06         −2.74003
  CAPN9                  1.65*E* − 10   4.32*E* − 06         −1.77713
  PTPRH                  1.70*E* − 10   4.43*E* − 06         −1.93474
  SST                    1.81*E* − 10   4.73*E* − 06         −2.35448
  HEPACAM2               1.82*E* − 10   4.76*E* − 06         −2.85009
  SMPDL3A                2.03*E* − 10   5.31*E* − 06         −1.85516
  UGT2A3                 2.16*E* − 10   5.65*E* − 06         −2.42200
  TRPM6                  2.42*E* − 10   6.34*E* − 06         −2.40017
  CES2                   2.58*E* − 10   6.74*E* − 06         −1.80950
  NR5A2                  2.64*E* − 10   6.91*E* − 06         −1.65550
  DHRS11                 2.77*E* − 10   7.25*E* − 06         −2.40964
  ENTPD5                 2.88*E* − 10   7.52*E* − 06         −1.91140
  PLCL2                  2.98*E* − 10   7.79*E* − 06         −1.71267
  MYO1A                  2.98*E* − 10   7.79*E* − 06         −1.82841
  BTNL8                  3.28*E* − 10   8.58*E* − 06         −2.68136
  PLCD1                  3.40*E* − 10   8.88*E* − 06         −1.69423
  ADTRP                  3.71*E* − 10   9.69*E* − 06         −2.66899
  ARL14                  4.37*E* − 10   1.14*E* − 05         −2.10661
  PDZD3                  4.78*E* − 10   1.25*E* − 05         −1.73340
  SCNN1B                 5.25*E* − 10   1.37*E* − 05         −2.51853
  MEP1A                  5.25*E* − 10   1.37*E* − 05         −2.15953
  C2orf88                5.40*E* − 10   1.41*E* − 05         −2.60606
  GPA33                  5.69*E* − 10   1.49*E* − 05         −1.85470
  SCIN                   6.20*E* − 10   1.62*E* − 05         −2.19971
  MAOA                   6.61*E* − 10   1.73*E* − 05         −1.79573
  PIGZ                   6.89*E* − 10   1.80*E* − 05         −1.67717
  PYY                    6.96*E* − 10   1.82*E* − 05         −2.53788
  C4orf19                7.26*E* − 10   1.90*E* − 05         −1.57357
  TNFRSF17               7.47*E* − 10   1.95*E* − 05         −2.36650
  ADAMDEC1               7.47*E* − 10   1.95*E* − 05         −2.39500
  TEX11                  8.71*E* − 10   2.28*E* − 05         −2.24440
  CDHR2                  9.44*E* − 10   2.47*E* − 05         −1.71114
  TMEM171                9.64*E* − 10   2.52*E* − 05         −2.11860
  STMN2                  1.28*E* − 09   3.36*E* − 05         −2.05581
  PKIB                   1.45*E* − 09   3.78*E* − 05         −2.98037
  CLIC5                  1.57*E* − 09   4.11*E* − 05         −1.55858
  BMP2                   1.60*E* − 09   4.19*E* − 05         −1.76798
  RETSAT                 1.63*E* − 09   4.26*E* − 05         −1.68389
  PADI2                  1.69*E* − 09   4.42*E* − 05         −2.10023
  SLC9A2                 1.80*E* − 09   4.70*E* − 05         −1.55732
  CYP2C18                2.16*E* − 09   5.65*E* − 05         −1.71017
  C1orf115               2.32*E* − 09   6.05*E* − 05         −1.74460
  CEACAM1                2.42*E* − 09   6.31*E* − 05         −1.84011
  PDE9A                  2.44*E* − 09   6.37*E* − 05         −2.05665
  SLCO2A1                2.58*E* − 09   6.75*E* − 05         −1.53024
  BCAR3                  2.63*E* − 09   6.87*E* − 05         −1.50716
  METTL7A                2.65*E* − 09   6.92*E* − 05         −1.62515
  DSC2                   2.65*E* − 09   6.92*E* − 05         −1.44448
  IL1R2                  2.75*E* − 09   7.19*E* − 05         −2.16852
  CCDC68                 2.75*E* − 09   7.19*E* − 05         −1.89156
  GDPD3                  2.78*E* − 09   7.28*E* − 05         −2.08667
  PDE6A                  2.81*E* − 09   7.34*E* − 05         −1.93721
  EPHX2                  3.12*E* − 09   8.16*E* − 05         −1.49186
  SPIB                   3.35*E* − 09   8.76*E* − 05         −2.27898
  ITPKA                  3.41*E* − 09   8.91*E* − 05         −1.62863
  SCUBE2                 3.66*E* − 09   9.57*E* − 05         −1.51582
  AMPD1                  4.13*E* − 09   0.000108             −1.81548
  SELENBP1               4.61*E* − 09   0.000120             −2.04099
  TFCP2L1                5.10*E* − 09   0.000133             −1.16817
  BTNL3                  5.13*E* − 09   0.000134             −2.10512
  VIPR1                  5.45*E* − 09   0.000142             −1.57631
  ZZEF1                  5.53*E* − 09   0.000144             −1.27744
  NAT2                   5.61*E* − 09   0.000147             −1.61058
  CDHR5                  5.81*E* − 09   0.000152             −1.97788
  PTGDR                  6.44*E* − 09   0.000168             −2.08658
  HHLA2                  7.58*E* − 09   0.000198             −1.91952
  PLCE1                  7.60*E* − 09   0.000199             −1.63459
  BEST4                  7.87*E* − 09   0.000206             −2.37175
  FUCA1                  8.12*E* − 09   0.000212             −1.41919
  FGFBP1                 8.12*E* − 09   0.000212             −1.45128
  MT1X                   8.24*E* − 09   0.000215             −1.87572
  SLC16A9                8.52*E* − 09   0.000223             −1.97426
  SEMA6A                 8.52*E* − 09   0.000223             −1.66469
  FXYD3                  8.58*E* − 09   0.000224             −1.39744
  DEFB1                  8.94*E* − 09   0.000233             −1.76340
  ACADS                  9.22*E* − 09   0.000241             −1.70299
  UGDH                   9.50*E* − 09   0.000248             −1.45862
  HRASLS2                1.06*E* − 08   0.000276             −1.48365
  CYP4F12                1.09*E* − 08   0.000284             −1.26493
  JCHAIN                 1.10*E* − 08   0.000288             −2.33454
  ABHD3                  1.13*E* − 08   0.000295             −1.54939
  VWA5A                  1.23*E* − 08   0.000321             −1.12976
  LDHD                   1.27*E* − 08   0.000332             −2.10259
  XDH                    1.28*E* − 08   0.000334             −1.53406
  INSL5                  1.29*E* − 08   0.000337             −2.42430
  SPINK5                 1.38*E* − 08   0.000359             −2.43812
  VILL                   1.50*E* − 08   0.000391             −1.41689
  SQRDL                  1.51*E* − 08   0.000396             −1.38225
  FABP2                  1.52*E* − 08   0.000398             −1.88374
  LGALS4                 1.61*E* − 08   0.000421             −1.42830
  DNASE1L3               1.65*E* − 08   0.000431             −1.82008
  SLC44A4                1.66*E* − 08   0.000434             −1.59136
  GOLM1                  1.68*E* − 08   0.000439             −1.20581
  RNF186                 1.72*E* − 08   0.000450             −1.21896
  GDPD2                  1.85*E* − 08   0.000484             −1.90186
  SLC22A18AS             1.85*E* − 08   0.000484             −1.62665
  MGLL                   1.91*E* − 08   0.000499             −1.32867
  B3GNT6                 1.92*E* − 08   0.000501             −1.59112
  IL6R                   1.92*E* − 08   0.000502             −1.86011
  RAPGEFL1               1.92*E* − 08   0.000502             −1.32000
  TRPM4                  1.94*E* − 08   0.000508             −1.34414
  ETFDH                  2.00*E* − 08   0.000522             −1.52397
  TMPRSS2                2.05*E* − 08   0.000536             −1.39816
  APOBR                  2.08*E* − 08   0.000544             −1.69871
  APPL2                  2.11*E* − 08   0.000551             −1.46951
  IQGAP2                 2.17*E* − 08   0.000566             −1.55628
  FAM83E                 2.17*E* − 08   0.000568             −1.17487
  ETHE1                  2.29*E* − 08   0.000599             −1.61458
  FLVCR2                 2.39*E* − 08   0.000624             −1.01211
  ALDH1A1                2.41*E* − 08   0.000631             −1.28928
  DENND2A                2.51*E* − 08   0.000657             −1.32793
  HRCT1                  2.57*E* − 08   0.000671             −1.58787
  ATP8B1                 2.69*E* − 08   0.000703             −1.00964
  A1CF                   2.74*E* − 08   0.000715             −1.36877
  ELOVL6                 2.96*E* − 08   0.000773             −1.08274
  C11orf86               3.02*E* − 08   0.000789             −2.11210
  TMEM100                3.14*E* − 08   0.000821             −1.69604
  ASAP3                  3.27*E* − 08   0.000854             −1.44474
  S100A14                3.29*E* − 08   0.000859             −1.21353
  PHLPP2                 3.42*E* − 08   0.000892             −1.45264
  LIMA1                  3.47*E* − 08   0.000907             −1.20588
  FABP1                  3.51*E* − 08   0.000916             −1.62316
  FMO5                   3.62*E* − 08   0.000947             −1.41152
  LRMP                   3.64*E* − 08   0.000950             −1.84646
  UGP2                   3.68*E* − 08   0.000961             −1.28750
  ATP2A3                 3.74*E* − 08   0.000978             −1.51001
  SLC22A5                3.74*E* − 08   0.000978             −1.30616
  FAM46C                 3.78*E* − 08   0.000989             −1.41521
  LXN                    3.97*E* − 08   0.001037             −1.10935
  CDKN2B                 3.98*E* − 08   0.001039             −2.23550
  HMOX1                  3.99*E* − 08   0.001043             −1.23547
  NEDD4L                 4.03*E* − 08   0.001054             −1.23680
  CLDN7                  4.18*E* − 08   0.001093             −1.29905
  PARM1                  4.21*E* − 08   0.001099             −1.52095
  HSD3B2                 4.29*E* − 08   0.001120             −2.26639
  KIAA0513               4.39*E* − 08   0.001146             −1.22322
  ACADVL                 4.50*E* − 08   0.001176             −1.23429
  SYTL2                  4.74*E* − 08   0.001238             −1.07640
  SLC1A1                 4.79*E* − 08   0.001251             −1.40176
  CNTN3                  4.81*E* − 08   0.001256             −2.13362
  CNNM4                  4.97*E* − 08   0.001300             −1.36807
  CASP7                  5.04*E* − 08   0.001317             −1.34691
  GLTP                   5.30*E* − 08   0.001385             −1.40471
  PGM1                   5.49*E* − 08   0.001435             −1.23037
  ERN2                   5.60*E* − 08   0.001464             −1.10843
  NAAA                   5.72*E* − 08   0.001494             −1.45647
  GNA11                  6.10*E* − 08   0.001593             −1.40416
  CCL23                  6.37*E* − 08   0.001665             −1.50079
  STYK1                  6.40*E* − 08   0.001673             −1.56848
  CFD                    6.56*E* − 08   0.001715             −1.80374
  C15orf48               6.82*E* − 08   0.001783             −1.45026
  OASL                   6.89*E* − 08   0.001800             −1.13508
  GPT                    6.99*E* − 08   0.001827             −1.44289
  CLDN23                 7.12*E* − 08   0.001859             −1.93577
  MB                     7.62*E* − 08   0.001991             −1.42542
  HIGD1A                 7.65*E* − 08   0.002000             −1.40813
  EMP1                   8.37*E* − 08   0.002188             −1.46200
  ADH1B                  8.46*E* − 08   0.002211             −2.01430
  LPAR1                  8.49*E* − 08   0.002219             −1.26559
  GPAT3                  8.70*E* − 08   0.002272             −2.01808
  CHGB                   8.90*E* − 08   0.002324             −1.55043
  P3H2                   9.09*E* − 08   0.002376             −1.48288
  PRKACB                 9.28*E* − 08   0.002424             −1.46492
  OSBPL1A                9.84*E* − 08   0.002572             −1.16940
  SPINK4                 1.04*E* − 07   0.002716             −1.69181
  MT2A                   1.04*E* − 07   0.002726             −1.55590
  SULT1B1                1.07*E* − 07   0.002807             −1.66731
  NAT1                   1.08*E* − 07   0.002828             −1.17391
  ADRA2A                 1.11*E* − 07   0.002892             −1.54370
  MEP1B                  1.13*E* − 07   0.002960             −2.16734
  LPCAT4                 1.18*E* − 07   0.003077             −1.02702
  PCSK7                  1.18*E* − 07   0.003077             −1.00185
  ST6GALNAC1             1.18*E* − 07   0.003088             −1.65355
  SGK2                   1.21*E* − 07   0.003160             −1.41158
  GRAMD3                 1.26*E* − 07   0.003287             −1.25518
  RIOK3                  1.27*E* − 07   0.003331             −1.21281
  CITED2                 1.29*E* − 07   0.003374             −1.11561
  CXCL12                 1.41*E* − 07   0.003684             −1.54414
  ITM2A                  1.45*E* − 07   0.003786             −1.47880
  SEPP1                  1.51*E* − 07   0.003956             −1.10723
  KBTBD11                1.53*E* − 07   0.004006             −1.05544
  RHOF                   1.55*E* − 07   0.004040             −1.11757
  GSTA1                  1.57*E* − 07   0.004105             −1.34829
  GALNT12                1.61*E* − 07   0.004214             −1.23449
  BCHE                   1.70*E* − 07   0.004446             −1.57410
  HGD                    1.78*E* − 07   0.004657             −1.24750
  HOXD1                  1.83*E* − 07   0.004793             −1.79058
  FGL2                   1.90*E* − 07   0.004977             −1.31339
  ATP8A1                 2.03*E* − 07   0.005307             −1.05015
  HIST1H1C               2.06*E* − 07   0.005393             −1.25170
  MYOT                   2.10*E* − 07   0.005480             −1.72660
  PBLD                   2.11*E* − 07   0.005502             −1.58127
  RBM47                  2.15*E* − 07   0.005614             −1.08864
  CES3                   2.18*E* − 07   0.005700             −1.45856
  CD1D                   2.18*E* − 07   0.005704             −1.29631
  FAM150B                2.19*E* − 07   0.005719             −1.50655
  RARRES1                2.23*E* − 07   0.005819             −1.46770
  LGALS9                 2.24*E* − 07   0.005842             −1.01981
  KLK1                   2.27*E* − 07   0.005936             −1.29450
  TOX                    2.27*E* − 07   0.005942             −1.29132
  ACVRL1                 2.36*E* − 07   0.006175             −1.13083
  CPT2                   2.44*E* − 07   0.006372             −1.22566
  SGK1                   2.57*E* − 07   0.006718             −1.64587
  ALPI                   2.62*E* − 07   0.006834             −1.09455
  SLC51B                 2.65*E* − 07   0.006919             −2.27581
  SLC20A1                2.71*E* − 07   0.007076             −1.03315
  SCGN                   2.74*E* − 07   0.007164             −1.86108
  ASPA                   2.75*E* − 07   0.007186             −1.45497
  FAM107B                2.81*E* − 07   0.007337             −1.24898
  AGR3                   2.82*E* − 07   0.007358             −1.80558
  HOXA5                  2.85*E* − 07   0.007437             −1.09160
  NPY1R                  2.97*E* − 07   0.007754             −1.92966
  TNFSF10                2.97*E* − 07   0.007754             −1.20956
  FAM107A                3.18*E* − 07   0.008318             −1.40373
  MUC4                   3.26*E* − 07   0.008520             −1.83234
  TST                    3.31*E* − 07   0.008645             −1.30505
  NXPE1                  3.57*E* − 07   0.009326             −1.90526
  SPON1                  3.60*E* − 07   0.009400             −1.78810
  ST6GALNAC6             3.78*E* − 07   0.009874             −1.79857

FC: fold change.

###### 

Detailed information on the six microarrays from the GEO database.

  Reference                           Tissue   GEO        Platform   Normal   Tumor
  ----------------------------------- -------- ---------- ---------- -------- -------
  Hinoue et al. \[[@B22]\]            CRC      GSE25070   GPL6883    51       51
  Cordero et al. \[[@B23]--[@B26]\]   CRC      GSE44076   GPL13667   148      98
  Ryan et al. \[[@B27]\]              CRC      GSE44861   GPL3921    55       56
  Tsukamoto et al. \[[@B28]\]         CRC      GSE21510   GPL570     25       123
  Hong et al. \[[@B29]\]              CRC      GSE9348    GPL570     12       70
  Mimori et al. \[[@B30], [@B31]\]    CRC      GSE21815   GPL6480    9        132

###### 

GUCA2A coexpressed genes in the TCGA database.

  Genes           Correlation   *P* value
  --------------- ------------- ---------------
  GUCA2A          1             0
  TMIGD1          0.81034948    6.78*E* − 145
  CA4             0.78988642    1.02*E* − 132
  GUCA2B          0.78006796    2.39*E* − 127
  SCNN1B          0.76922102    9.92*E* − 122
  CDKN2B-AS1      0.75976020    4.48*E* − 117
  LINC00974       0.72826962    5.10*E* − 103
  CA1             0.72589778    4.85*E* − 102
  OTOP2           0.72524636    8.98*E* − 102
  B3GNT7          0.69874083    1.59*E* − 91
  CA2             0.69872813    1.60*E* − 91
  CLDN8           0.69162255    5.79*E* − 89
  CLCA4           0.68724381    2.01*E* − 87
  MS4A12          0.67084612    6.81*E* − 82
  CEACAM7         0.65697702    1.74*E* − 77
  BTNL3           0.64672606    2.24*E* − 74
  SLC25A34        0.64457072    9.77*E* − 74
  C11orf86        0.64075941    1.28*E* − 72
  CLDN23          0.64014863    1.93*E* − 72
  EDN3            0.62755226    7.21*E* − 69
  RP11-35P15.1    0.62358770    8.90*E* − 68
  B3GALT5-AS1     0.62060619    5.75*E* − 67
  SULT1A2         0.61591517    1.04*E* − 65
  PYY             0.61445537    2.53*E* − 65
  ZG16            0.61434490    2.71*E* − 65
  ALPI            0.61109844    1.93*E* − 64
  SLC25A47P1      0.60742616    1.73*E* − 63
  BTNL8           0.60619878    3.58*E* − 63
  BEST4           0.59344211    5.70*E* − 60
  CD177           0.59322686    6.44*E* − 60
  ST6GALNAC6      0.59074429    2.60*E* − 59
  CDHR5           0.58538873    5.07*E* − 58
  TRPM6           0.57770739    3.26*E* − 56
  SEPP1           0.57757017    3.51*E* − 56
  KRTAP13-2       0.57186209    7.21*E* − 55
  SLC4A4          0.56853673    4.08*E* − 54
  RP11-203J24.9   0.55828248    7.58*E* − 52
  MYPN            0.55589062    2.50*E* − 51
  RP11-202A13.1   0.54993651    4.66*E* − 50
  SLC30A10        0.54640858    2.57*E* − 49
  SLC26A3         0.54279335    1.45*E* − 48
  SMPD1           0.54142083    2.77*E* − 48
  CDKN2B-AS       0.53902904    8.55*E* − 48
  RN7SKP127       0.53769807    1.59*E* − 47
  HHLA2           0.53644205    2.86*E* − 47
  TMEM82          0.53029307    4.85*E* − 46
  LYPD8           0.52880179    9.56*E* − 46
  CD177P1         0.52733551    1.85*E* − 45
  SCNN1G          0.52521670    4.81*E* − 45
  ABCC13          0.52358277    9.98*E* − 45
  GDPD2           0.51942104    6.29*E* − 44
  TTC22           0.51932599    6.56*E* − 44
  B3GALT5         0.51777531    1.29*E* − 43
  C2orf88         0.51755217    1.43*E* − 43
  DHRS9           0.51539770    3.64*E* − 43
  TSPAN1          0.51536862    3.69*E* − 43
  INSL5           0.51280701    1.11*E* − 42
  TMEM253         0.50785220    9.21*E* − 42
  SDCBP2          0.50717257    1.23*E* − 41
  SLC17A4         0.50515764    2.86*E* − 41
  PLAC8           0.50131456    1.42*E* − 40
  MMP28           0.49830422    4.90*E* − 40
  PPY             0.49796769    5.62*E* − 40
  PLA2G10         0.49555028    1.51*E* − 39
  GLRA4           0.49493081    1.94*E* − 39
  ITM2C           0.49231037    5.57*E* − 39
  TRIM40          0.49190614    6.55*E* − 39
  SMPDL3A         0.49188755    6.60*E* − 39
  MALL            0.49120642    8.68*E* − 39
  BCAS1           0.49019232    1.30*E* − 38
  CDKN2B          0.48925853    1.89*E* − 38
  SLC51B          0.48708976    4.46*E* − 38
  BMP3            0.48536366    8.79*E* − 38
  AMPD1           0.48202823    3.23*E* − 37
  ENTPD5          0.47054777    2.56*E* − 35
  PTPRH           0.46882533    4.87*E* − 35
  RPL12P14        0.46759668    7.68*E* − 35
  RP11-92A5.2     0.46652136    1.14*E* − 34
  AC106869.2      0.46640139    1.19*E* − 34
  MUC12           0.46578524    1.50*E* − 34
  CASC18          0.46570335    1.55*E* − 34
  PEX26           0.46071845    9.52*E* − 34
  TMEM72          0.46026123    1.12*E* − 33
  GLDN            0.45995677    1.25*E* − 33
  TEX11           0.45994953    1.26*E* − 33
  NAAA            0.45741196    3.13*E* − 33
  TRANK1          0.45665719    4.10*E* − 33
  SMIM6           0.45572985    5.71*E* − 33
  LINC00507       0.44872641    6.70*E* − 32
  AOC1            0.44821442    8.01*E* − 32
  CDHR2           0.44663931    1.38*E* − 31
  APPL2           0.44091022    9.81*E* − 31
  TMPRSS2         0.43862005    2.12*E* − 30
  CCDC152         0.43855903    2.17*E* − 30
  TRPV3           0.43605403    5.02*E* − 30
  NPY2R           0.43603750    5.04*E* − 30
  GNA11           0.43389107    1.03*E* − 29
  ACVRL1          0.43021941    3.44*E* − 29
  SEMA6D          0.42947338    4.39*E* − 29
  GPR15           0.42871749    5.62*E* − 29
  RP1-117B12.4    0.40855340    3.19*E* − 26

[^1]: Academic Editor: Robert Speth
